Imunon Inc (IMNN)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$0.90-0.74%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · IMNN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | FY 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | — | — | — | — | — | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | — | — | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||||||||
| R&D Expenses | 8.2 | — | 7.8 | 11.6 | 11.3 | 11.7 | 10.6 | 11.3 | 13.1 | 11.9 | 13.1 | 14.6 | 14.7 | 15.0 | 9.4 | 15.8 | 19.9 |
| Operating Income | (14.8) | — | (14.7) | (19.1) | (21.0) | (24.9) | (21.0) | (18.5) | (20.6) | (21.1) | (18.5) | (20.6) | (20.8) | (24.7) | (15.4) | (22.1) | (23.0) |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | — | — | — | 0.2 | 5.0 | 0.6 | 1.3 | — | — | — | — | — | — | — | 0.4 | — |
| Interest & Investment Income | — | — | — | — | — | — | — | 0.1 | 0.5 | 0.4 | 0.0 | 0.0 | 0.1 | 0.1 | (0.0) | 0.1 | 0.2 |
| Net Interest Expenses | — | — | — | — | — | — | — | 1.2 | — | — | — | — | — | — | — | 0.3 | — |
| Other Non-Operating Income / Expenses | — | — | 0.2 | 0.5 | 0.2 | (12.5) | (1.1) | (4.8) | 1.9 | (1.2) | (1.9) | (1.4) | (1.6) | (0.8) | 7.2 | (4.4) | (0.2) |
| Asset Writedown | — | — | — | — | — | — | — | — | 2.4 | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | — | 14.5 | (18.6) | (20.8) | (37.5) | (22.2) | (23.3) | (18.7) | (22.3) | — | — | — | — | — | — | (23.2) |
| Income Tax Expense | — | — | — | — | (1.3) | (1.6) | (1.4) | (1.8) | (1.8) | (10.4) | — | — | — | — | — | — | 0.0 |
| Net Income | |||||||||||||||||
| Net Income | 14.3 | — | (14.5) | (18.6) | (19.5) | (35.9) | (20.8) | (21.5) | (16.9) | (11.9) | (20.4) | (22.1) | (22.5) | (25.5) | (8.3) | (26.6) | (23.2) |
| Per Share | |||||||||||||||||
| Basic EPS | 2.73 | — | (6.83) | (1.62) | (2.16) | (5.03) | (3.83) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | 2.73 | — | (6.83) | (1.62) | (2.16) | (5.03) | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 0.15 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 5.2 | — | 2.1 | 11.5 | 9.0 | 7.1 | 5.4 | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 5.2 | — | 2.1 | 11.5 | 9.0 | 7.1 | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||||||
| EBITDA | — | — | — | (18.9) | (20.8) | (24.7) | (20.3) | (17.7) | (19.8) | (20.7) | (17.9) | (19.6) | (20.4) | (24.3) | (15.1) | (21.9) | (22.8) |
| EBIT | (14.8) | — | (14.7) | (19.1) | (21.0) | (24.9) | (21.0) | (18.5) | (20.6) | (21.1) | (18.5) | (20.6) | (20.8) | (24.7) | (15.4) | (22.1) | (23.0) |
| Effective Tax Rate | — | — | — | — | 6.2% | 4.2% | 6.2% | 7.9% | 9.7% | 46.7% | — | — | — | — | — | — | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.